Relationship between the Door-to-TIMI-3 Flow Time and the Infarct Size in Patients Suffering from Acute Myocardial Infarction - Analysis Based on the Fibrinolysis and Subsequent Transluminal (FAST-3) Trial

Circulation Journal

Volumn 68, Issue 4, 2004, Pages 280-285

  Watanabe, Kazuhiro ^a   Nagao, Ken ^b   Watanabe, Ikuyoshi ^a   Kanmatsuse, Katsuo ^b  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Thrombolysis; TIMI 3 flow time

Indexed keywords

CREATINE KINASE; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; FIBRINOLYSIS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE INJURY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE REGRESSION; PREDICTION; RISK;

AGED; ANTICOAGULANTS; ASPIRIN; BIOLOGICAL MARKERS; CORONARY CIRCULATION; CREATINE KINASE; CREATINE KINASE, MB FORM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEPARIN; HOSPITALS, UNIVERSITY; HUMANS; ISOENZYMES; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT ADMISSION; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RISK FACTORS; STROKE VOLUME; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TROPONIN T; URINARY PLASMINOGEN ACTIVATOR;

EID: 1842783445     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.280     Document Type: Article

References (22)

1. Guideline 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Circulation 2000; 102: I-172-I-203.
2. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratsuka LF, et al. ACC/AHA guidelines for management of patients with acute myocardial infarction. Circulation 1999; 100: 1016-1030.
3. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation (ILCOR). Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: An international consensus on science. Circulation 2000; 102: I-1-I-384.
4. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-1348.
5. Takahashi H, Watanabe I, Nagao K, Kanmatsuse K. The effects and problems of combination reperfusion therapy (FAST therapy: Fibrinolysis and subsequent transluminal therapy) in patients with acute myocardial infarction. J Jpn Coron Assoc 2000; 6: 6-9 (in Japanese).
6. Nagao K, Kanmatsuse K, Kikuchi S, Satou K, Watanabe I, Arima K, et al. Combination reperfusion strategy of fibrinolysis and subsequent transluminal therapy for acute myocardial infarction: The FAST trial (abstract). Jpn Circ J 2001; 65(Suppl): 18.
7. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of sympton-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-2947.
8. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major mortality results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311-322.
9. GISSI Study Group. Long-term effect of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study. Lancet 1987; 2: 871-874.
10. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996; 348: 771-775.
11. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270: 1211-1216.
12. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
13. GISSI-1 (Gruppo Italiano per to Studio della Sopravvivenza nellíInfarto Miocardico-2). A factorial randomized trial of alteplase versus streptokinase snd heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
14. Okuda J, Kimura K, Kosuge M, Endo T, Sugano T, Nakatogawa T, et al. Significance of thrombolysis in myocardial infarction (TIMI) grade 2 flow early after thrombolysis followed by immediated percutaneous coronary intervention in patients with acute myocardial infarction. Circ J 2003; 67: 238-242.
15. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. J Am Coll Cardiol 1999; 34: 1954-1962.
16. Zahger D, Cercek B, Cannon CP, Jordan M, Davis V, Braunwald E, et al. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial). Am J Cardiol 1995; 75: 232-236.
17. Grines CL, Topol EJ, O'Neill WW, George BS, Kereiakes D, Phillips HR, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298-303.
18. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomized study. Lancet 2002; 360: 825-829.
19. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-389.
20. Nagao K, Hayashi N, Arima K, Ooiwa K, Kikushima K, Anazawa T, et al. Effects of combined emergency percutaneous cardiopulmonary support and reperfusion treatment in patients with refractory ventricular fibrillation complicating acute myocardial infarction. Intern Med 1999; 38: 710-716.
21. Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K, et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol 2000; 36: 776-783.
22. Nagao K, Hayashi N, Kanmatsuse K, Kikuchi S, Ohuba T, Takahashi H, et al. An early and complete reperfusion strategy for acute myocardial infarction using fibinolysis and subsequent transluminal therapy: The FAST trial. Circ J 2002; 66: 576-582.